Recurrent hydatidiform moles: detection of a new mutation in the NLRP7 gene in the family

Authors

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20231943

Keywords:

Recurrent hydatidiform moles, NLRP7, Mutation

Abstract

Hydatidiform moles are the most common type of gestational trophoblastic neoplasia. Hyperproliferative vesicular trophoblasts and imperfect fetal development are abnormal pregnancies, and recurrent hydatidiform moles are rare. Mutations in NLRP7 are responsible for recurrent hydatidiform mole. Genetic heterogeneity has been demonstrated in patients with the NLRP7 mutation. This study presents our case with gravida 11, parity 0, histopathologically diagnosed with six hydatidiform moles and five missed abortion histories at age 35. Karyotype analyses of the unrelated couple were normal. A genetic examination revealed a novel mutation of the NLRP7 gene in the patient, his brother, and his parents. Detecting a new NLRP7 mutation in recurrent hydatidiform moles cases provides further evidence for the predetermined role of NLRP7 mutations in the pathophysiology of recurrent moles hydatidiform. Based on our findings, we hope to contribute to the literature by expanding the spectrum of recurrent pregnancy loss associated with NLRP7 mutations in patients.

References

Gadducci A, Lanfredini N, Cosio S. Reproductive outcomes after hydatidiform mole and gestational trophoblastic neoplasia. Gynecological Endocrinology. 2015;31(9):673-8.

Novac L, Niculescu M, Manolea MM. The vasculogenesis - A possible histological identification criterion for the molar pregnancy. Romanian Journal of Morphology and Embryology. 2011;52(1):61-7.

Candelier JJ. The hydatidiform mole. Cell Adh Migr. 2016;10(1-2):226-35.

Kalogiannidis I, Kalinderi K, Kalinderis M, Miliaras D, Tarlatzis B, Athanasiadis A. Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review. J Assist Reprod Genet. 2018;35(6):967-73.

Rosemary F, Matthew H, Edward N. Familial recurrent hydatidiform mole: A review. J Reprod Med. 2004;49:595-601.

Ji M, Shi X, Xiang Y, Cui Q, Zhao J. NLRP7 and KHDC3L variants in Chinese patients with recurrent hydatidiform moles. Jpn J Clin Oncol. 2019;49(7):620-7.

Eagles N, Sebire NJ, Short D, Savage PM, Seckl MJ, Fisher RA. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Human Reproduction. 2015;30(9):2055-63.

Murdoch S, Djuric U, Mazhar B. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38(3):300-2.

Hayward BE, De Vos M, Talati N. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat. 2009;30(5):629-39.

Al-Ghamdi A. Recurrent hydatidiform mole: A case report of six consecutive molar pregnancies complicated by choriocarcinoma, and review of the literature. J Family Community Med. 2011;18(3):159-61.

Fallahi J, Razban V, Momtahan M, Akbarzadeh-Jahromi M. A novel mutation in NLRP7 related to recurrent hydatidiform mole and reproductive failure. Int J Fertil Steril. 2019;13(2):135-8.

Qian J, Deveault C, Bagga R, Xie X, Slim R. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations. Hum Mutat. 2007;28(7):741.

Abdalla EM, Hayward BE, Shamseddin A, Nawar MM. Recurrent hydatidiform mole: Detection of two novel mutations in the NLRP7 gene in two Egyptian families. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2012;164(2):211-5.

Saleem A, Masoom K. A case of consecutive molar pregnancies followed by choriocarcinoma. J Coll Physicians Surg Pak. 2003;13(3):161-3.

Fisher RA, Lavery SA, Carby A. What a difference an egg makes. The Lancet. 2011;378(9807):1974.

Akoury E, Gupta N, Bagga R. Live births in women with recurrent hydatidiform mole and two NLRP7 mutations. Reprod Biomed Online. 2015;31(1):120-4.

Downloads

Published

2023-06-28

Issue

Section

Case Reports